These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. Johnson BA; Wells LT; Roache JD; Wallace C; Ait-Daoud N; Wang Y Am J Hypertens; 2005 Jun; 18(6):813-22. PubMed ID: 15925741 [TBL] [Abstract][Full Text] [Related]
5. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects. Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463 [TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration. Dulac O; Alvarez JC Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218 [TBL] [Abstract][Full Text] [Related]
7. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers. Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894 [TBL] [Abstract][Full Text] [Related]
9. Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. Johnson BA; Roache JD; Ait-Daoud N; Wallace CL; Wells LT; Wang Y; Dawes MA Int J Neuropsychopharmacol; 2005 Dec; 8(4):549-56. PubMed ID: 15916717 [TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults. Reiz JL; Donnelly GA; Michalko K Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243 [TBL] [Abstract][Full Text] [Related]
11. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users. Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677 [TBL] [Abstract][Full Text] [Related]
12. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study. Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242 [TBL] [Abstract][Full Text] [Related]
13. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects. Datto C; Berggren L; Patel JB; Eriksson H Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers. Darwish M; Chang S; Hellriegel ET Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711 [TBL] [Abstract][Full Text] [Related]
16. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. Johnson BA; Roache JD; Ait-Daoud N; Wallace C; Wells L; Dawes M; Wang Y Int J Neuropsychopharmacol; 2005 Jun; 8(2):203-13. PubMed ID: 15850499 [TBL] [Abstract][Full Text] [Related]
17. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations. Turner SW; Jungbluth GL; Knuth DW Biopharm Drug Dispos; 2002 Dec; 23(9):369-77. PubMed ID: 12469330 [TBL] [Abstract][Full Text] [Related]
18. In vivo performance of controlled release pellets of diltiazem HCl. Nisarur-ur-Rahman ; K H Y; Jia Woei W Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398 [TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability cf two amlodipine formulation in healthy volunteers. Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060 [TBL] [Abstract][Full Text] [Related]
20. Effects of sustained-release isradipine on blood pressure and peripheral hemodynamics in hypertensive patients. Arosio E; Pancera P; Priante F; Ribul M; De Marchi S; Lechi A Clin Ther; 1993; 15(4):705-13. PubMed ID: 8221821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]